Signal transduction by basic fibroblast growth factor in rat osteoblastic Py1a cells

Area of Science:

• Molecular Biology
• Cell Signaling
• Biochemistry

Background:

• Basic fibroblast growth factor (bFGF) is a known mitogen for bone cells.
• Understanding the signal transduction pathways of bFGF is crucial for bone biology research.

Purpose of the Study:

• To investigate the signal transduction mechanisms of bFGF in rat osteoblastic cells (Py1a).
• To determine the role of mitogen-activated protein kinases (MAPK) and c-fos mRNA induction in bFGF's mitogenic response.
• To compare the signaling pathways of bFGF and phorbol myristate acetate (PMA).

Main Methods:

• Utilized the Py1a rat osteoblastic cell line.
• Assessed [3H]thymidine incorporation (TDR) to measure DNA synthesis.
• Employed inhibitors: genistein (tyrosine kinase inhibitor) and H-7 (PKC inhibitor).
• Analyzed protein tyrosine phosphorylation and MAPK activation via immunoblotting.
• Quantified c-fos mRNA expression.

Main Results:

• Both bFGF and PMA significantly increased TDR, MAPK tyrosine phosphorylation, and c-fos mRNA expression.
• Genistein blocked bFGF's mitogenic effect and partially inhibited PMA's, also blocking c-fos induction by both agents.
• PKC inhibition (H-7) or downregulation (PMA pretreatment) differentially affected bFGF and PMA signaling, impacting c-fos and mitogenesis but not bFGF-induced MAPK phosphorylation.

Conclusions:

• bFGF and PMA share common signaling elements, including MAPK activation and c-fos induction.
• The signaling pathways diverge, particularly concerning the role of protein kinase C (PKC).
• PKC plays a critical role in the downstream effects of PMA but not in the initial MAPK activation by bFGF.